Cell targeting strategy affects the intracellular trafficking of liposomes altering loaded doxorubicin release kinetics and efficacy in endothelial cells

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Targeting nanocarrier drug delivery systems, that deliver drug payloads to the site of disease action, are frequently viewed as the future of nanocarrier based therapies but have struggled to breakthrough to the clinic in comparison to non-targeting counterparts. Using unilamellar liposomes as model nanocarriers, we show that cell targeting strategy (electrostatic, ligand and antigen) influences both the intracellular fate of the liposomes and the corresponding efficacy of the loaded drug, doxorubicin, in endothelial cells. We show that increased liposome uptake by cells does not translate to improved efficacy in this scenario but that liposome intracellular trafficking, particularly distribution between recycling endosomes and lysosomes, influences in vitro efficacy. Choosing targeting strategies that promote desired nanocarrier intracellular trafficking may be a viable strategy to enhance the in vivo efficacy of drug delivery systems.
Original languageEnglish
Article number119715
JournalINTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume588
Number of pages10
ISSN0378-5173
DOIs
Publication statusPublished - 2020

Keywords

  • Liposomes
  • Trafficking
  • Endosomes
  • Targeting
  • Endothelial cell
  • Doxorubicin

Fingerprint Dive into the research topics of 'Cell targeting strategy affects the intracellular trafficking of liposomes altering loaded doxorubicin release kinetics and efficacy in endothelial cells'. Together they form a unique fingerprint.

Cite this